Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Recruiting 1Available 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 1Expanded_access 1

Sponsor

Cancer Type

Head & Neck 2Endocrine 1

Conditions

Parathyroid Neoplasms 2Multiple Endocrine Neoplasia Type 1 1Hyperparathyroidism, Primary 1

Interventions

pembrolizumab 183Cisplatin 158Radiotherapy 77Carboplatin 71Radiotherapy, Intensity-Modulated 70Cetuximab 68Magnetic Resonance Spectroscopy 65Nivolumab 64Paclitaxel 52Docetaxel 50Specimen Handling 45Radiation 34Gemcitabine 33Fluorouracil 31Surveys and Questionnaires 28Biopsy 27Drug Therapy 26toripalimab 25Platinum 25Surgical Procedures, Operative 24Standard of Care 231,2-diaminocyclohexaneplatinum II citrate 23cemiplimab 22Capecitabine 21atezolizumab 20Chemoradiotherapy 20Ipilimumab 19tislelizumab 18durvalumab 18Taxes 17

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
fluorocholine × Head & Neck × 1 year × Clear all
NCT07444723 2026-05-12

Accuracy of 18F-Fluorocholine PET/MR and NeuroEXPLORER PET/CT Imaging for Localization of Parathyroid Tumors

National Institutes of Health Clinical Center (CC)

Phase 2/3 Recruiting
193 enrolled
EndocrineHead & Neck

Parathyroid Neoplasms, Multiple Endocrine Neoplasia Type 1, Hyperparathyroidism, Primary

NCT07218224 2025-10-20

Expanded Access:18F-Fluorocholine for the Detection of Parathyroid Adenomas

University of California, San Francisco

Available
Head & Neck

Parathyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡